(R)-(-)-1-Aminoindane - CAS 10277-74-4
Catalog: |
BB000946 |
Product Name: |
(R)-(-)-1-Aminoindane |
CAS: |
10277-74-4 |
Synonyms: |
(1R)-2,3-dihydro-1H-inden-1-amine; (1R)-2,3-dihydro-1H-inden-1-amine |
IUPAC Name: | (1R)-2,3-dihydro-1H-inden-1-amine |
Description: | An intermediate for Rasagiline Mesylate.Rasagiline is an irreversible inhibitor of monoamine oxidase-B. It can be used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. |
Molecular Weight: | 133.19 |
Molecular Formula: | C9H11N |
Canonical SMILES: | C1CC2=CC=CC=C2C1N |
InChI: | InChI=1S/C9H11N/c10-9-6-5-7-3-1-2-4-8(7)9/h1-4,9H,5-6,10H2/t9-/m1/s1 |
InChI Key: | XJEVHMGJSYVQBQ-SECBINFHSA-N |
Boiling Point: | 96 °C (8 mmHg) |
Purity: | > 95 % |
Density: | 1.038 g/cm3 |
Appearance: | Clear brown to dark brown oil |
MDL: | MFCD00216669 |
LogP: | 2.33290 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P391, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112280761-A | Recombinant transaminase, mutant of recombinant transaminase and application of mutant | 20201116 |
CN-113030283-A | Rasagiline genotoxic impurity compound and preparation method and application thereof | 20191225 |
WO-2020221209-A1 | Cd73 inhibitor, preparation method therefor and application thereof | 20190428 |
CN-113366008-A | CD73 inhibitor, preparation method and application thereof | 20190428 |
TW-202106311-A | A CD73 inhibitor, its preparation method and application | 20190428 |
PMID | Publication Date | Title | Journal |
22761132 | 20120701 | Chiral amines as reagents for HPLC-MS enantioseparation of chiral carboxylic acids | Journal of separation science |
20919927 | 20110301 | Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease? | Antioxidants & redox signaling |
21338509 | 20110221 | Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro | BMC pharmacology |
20600573 | 20101101 | Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity | Progress in neurobiology |
20002521 | 20100301 | The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline | Journal of neurochemistry |
Complexity: | 122 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 133.089149355 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 133.089149355 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS